3917 |
Sapien 3 Technology Overview |
Alain G. Cribier |
Apr. 21. 16 |
3916 |
The Recent Updated Data - Which Stent Is the Most Efficacy |
Osamu Iida |
Apr. 21. 16 |
3915 |
Leave Nothing Behind Is Valid Concept?? |
Masahiko Fujihara |
Apr. 21. 16 |
3914 |
"Complex Stenting Made Simple - An Illustrative Case with the Ultimaster Stent" |
Fahim Haider Jafary |
Apr. 21. 16 |
3913 |
Ultimaster - From Pathological View |
Aloke V. Finn |
Apr. 21. 16 |
3912 |
"Ultimaster: Is This Really the Third Generation DES?" |
Satoru Sumitsuji |
Apr. 21. 16 |
3911 |
Optimization of BVS Implantation in Imaging or Angiography Guided PCI; In Real World Experiences |
Nigel Jepson |
Apr. 21. 16 |
3910 |
Risk of Scaffold Thrombosis Comparable to DES; GHOST-EU Propensity Matched Analysis |
Christoph Kurt Naber |
Apr. 21. 16 |
3909 |
Why Do We Need a Fully Bioresorbable Vascular Scaffold; From Absorb III and ABSORB Meta-Analysis to the Future |
Gregg W. Stone |
Apr. 21. 16 |
3908 |
SYNERGY : Latest Experience from Korea |
Duk-Woo Park |
Apr. 21. 16 |